512 — Grand Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$14.36bn
- HK$15.42bn
- HK$10.53bn
- 59
- 88
- 47
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 1,356 | 2,074 | 2,786 | 2,517 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -41.9 | -417 | -544 | 173 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -487 | -488 | -576 | -1,242 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,304 | 1,456 | 2,006 | 1,843 | — |
Capital Expenditures | -599 | -279 | -536 | -1,085 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 156 | -1,235 | -1,233 | -1,275 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -444 | -1,513 | -1,769 | -2,360 | — |
Financing Cash Flow Items | -232 | -132 | -159 | -145 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -710 | 774 | -333 | 327 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 147 | 777 | -83.8 | -309 | — |